Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

http://www.wikidata.org/entity/Q34329413

about

Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop AGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neurons Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats.Early postnatal overfeeding induces early chronic renal dysfunction in adult male rats.Angiogenesis and chronic kidney disease.Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.Association of versican turnover with all-cause mortality in patients on haemodialysis.Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs Promoting effects of the adipokine, apelin, on diabetic nephropathy.Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.Glomerular endothelial cell injury and cross talk in diabetic kidney disease Chaperonin-containing t-complex protein-1 subunit β as a possible biomarker for the phase of glomerular hyperfiltration of diabetic nephropathy High protein intake in neonatal period induces glomerular hypertrophy and sclerosis in adulthood in rats born with IUGR.Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.Diabetic angiopathy and angiogenic defects.The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.The Effects of Tumstatin on Vascularity, Airway Inflammation and Lung Function in an Experimental Sheep Model of Chronic Asthma.Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy.Abnormal angiogenesis in diabetic nephropathy.Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury Abnormalities in signaling pathways in diabetic nephropathy.Endothelial dysfunction as a potential contributor in diabetic nephropathy.Reconstruction is not renovation - the role of remodeling in asthma.Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.VEGF and podocytes in diabetic nephropathy.Pathophysiology of the diabetic kidney.Potential approaches to reverse or repair renal fibrosis.Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.Macro- and microvascular endothelial dysfunction in diabetes.Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.Endothelial factors and diabetic nephropathy.The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats.Antiangiogenic Therapy for Diabetic Nephropathy.Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression.

P2860

Q24305329-3A2800D4-A9DC-4AFF-BA3C-F792097D5823 Q28572264-DDDA69EC-198C-4FCA-B384-43DB674886C5 Q33300528-40456D68-DA5C-474C-BC5F-AF8C1AD297DB Q33490903-F03CAA7B-5B39-451A-88A0-0BF64E1730A4 Q34075013-96B6EB31-1F6C-4F2F-96D7-B281FA637199 Q34257934-6F34E92E-ACA7-444A-8346-F7DC0B66C8A1 Q34420828-A552EBC7-69F5-40DD-8F30-4533BD62F264 Q34441673-0EB4D449-BCC4-40E2-B96E-937C4139B611 Q34551722-D139806B-BF48-4601-B6D0-4E1B13BEE543 Q34663765-1C9B22BB-A379-4502-89DD-65D194C46DA8 Q34682220-25919FF4-9043-4A49-ADA6-25EB4DC8DC03 Q35010424-4C4EA4AA-8E61-4CBD-9EC1-C40B046F5AD1 Q35061522-36580ACE-2D01-4E33-A7F7-023AC79FAE93 Q35073189-301FEDEF-FF67-45E2-9905-3A30C59094D7 Q35086477-B8E9239A-A2F5-4A58-8196-7A28A239828A Q35470865-A95E0936-19BF-45D7-98A4-094160599EC5 Q35776247-B6D869F0-D1E5-470A-99EE-D3FE6644371E Q35780734-C96D43C8-AA20-419A-BD00-0CA28EBC9747 Q36301365-A09E1B8A-31F4-4F46-805E-163B7F9EECD0 Q36880835-5DEA7DE8-DE08-4F5D-A9E6-E7F0E989A488 Q36919220-463DCA23-A059-4446-A25D-6275D2906235 Q37207268-8143DC5D-D7E4-438A-9023-CCAC1B375A0C Q37236268-C182EFFC-FD57-40C4-9DFA-8D7891786447 Q37308921-6C90D6C4-38D1-45FC-B85F-DC4C0A6DB617 Q37360457-845F4315-8755-449E-B1B7-52C8773E0B10 Q37597721-A3819E22-7210-4DE0-B9E7-C9A3612CBF69 Q37708046-F5709204-11F2-434E-80F1-7B862F428CA7 Q37806614-FD2F4B6E-C8E5-42B4-85EE-D407411DD2AC Q37857701-F3FECC0D-B0DB-400B-ADD4-9CCDE489559B Q37959379-D3583B95-B9C3-452E-A2B1-087FB8D741B3 Q38041671-E0845FE7-5768-4300-82C0-E97C36283DEE Q38111707-DCB0BF9E-8F05-4247-B23C-45C07F266A74 Q38186986-DDAE5AB7-F9B3-45F6-A573-AE3B0188CEFF Q38317272-6BF0A07D-9F47-409A-AA2F-9100D463C183 Q39065434-23F7C695-D5E1-4136-9E03-F3B3CFD2097D Q39118882-F9AA423C-070D-486D-9EEC-2C1F9A1ABBF6 Q39988673-B107E1D7-0344-418C-9945-EA0BAB57B4BB Q41042820-CFEFBDF7-22A9-4351-9191-0C10CA160D73 Q41403094-0D2184BF-AA69-40A4-AC74-ABBC70D81708 Q42154701-6618097E-C464-459F-8339-3985EBF9D556

P2860

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

http://www.wikidata.org/entity/Q34329413

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@ast

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@en

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@nl

type

label

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@ast

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@en

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@nl

prefLabel

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@ast

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@en

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy.

@nl

P1433

Q34329413-232AF4FF-FC60-4A5B-8547-E97C2EBE74C5

P1476

Q34329413-426F7057-E879-44ED-ABCA-34DA0BAC42EA

P2093

Q34329413-093E54F5-E362-43D2-B15A-E52541587FA3

Q34329413-0FF0C500-466E-4804-8C6B-86747453F412

Q34329413-20CE88D6-E5E2-4F6F-A384-93EC402F4EC2

Q34329413-20E9C3A6-9873-4A3C-A7AF-8A0BC5F8D347

Q34329413-B1F2AD4D-88FF-4592-912C-3412BAE03BB0

Q34329413-CB23D890-1F25-4A6B-9934-150396582ED2

Q34329413-F40720AC-0CAE-46BE-987B-916E340EE29A

P304

Q34329413-8218B945-5A24-4745-BA60-73C55E71B131

P31

Q34329413-FC80B2D8-7AF3-44BA-9A7D-612CBABFCE3A

P356

Q34329413-0BCA98AC-3E99-4B73-A5D1-E6D2B5A18A72

P407

Q34329413-268BF416-9FDA-4B64-AA54-A3AB2CB5331D

P433

Q34329413-B70B8C0B-73D9-4453-8F64-590454E32B1B

P478

Q34329413-FE78BD56-B6CB-4CE9-A94E-F054C284C90B

P50

Q34329413-3AC31DF0-7818-4054-A6DA-EE20FC04A50F

P577

Q34329413-ECDC8D2E-4B1B-4D2C-AF23-3AB88024E3B9

P5875

Q34329413-3BEDEDE0-86C8-493F-973B-4A2EFF95AC5D

P698

Q34329413-2F6DEB61-E945-491D-A5F6-B7C49CE1E810

P356

DIABETES.53.7.1831

P1433

P1476

Tumstatin peptide, an inhibito ...... stage of diabetic nephropathy

@en

P2093

Hirofumi Makino

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kitayama

http://www.w3.org/2001/XMLSchema#string

Shinji Kitamura

http://www.w3.org/2001/XMLSchema#string

Yasushi Yamasaki

http://www.w3.org/2001/XMLSchema#string

Yohei Maeshima

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yuki Takazawa

http://www.w3.org/2001/XMLSchema#string

P304

1831-1840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIABETES.53.7.1831

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8488559

http://www.w3.org/2001/XMLSchema#string

P698

15220208

http://www.w3.org/2001/XMLSchema#string